Compare AGMB & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGMB | CNNE |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Belgium | United States |
| Employees | 62 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.4M | 609.0M |
| IPO Year | N/A | 2017 |
| Metric | AGMB | CNNE |
|---|---|---|
| Price | $11.69 | $14.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $32.00 | $20.25 |
| AVG Volume (30 Days) | 103.4K | ★ 446.6K |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 4.47% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $499,700,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.86 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $8.75 | $10.46 |
| 52 Week High | $17.82 | $21.88 |
| Indicator | AGMB | CNNE |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 53.88 |
| Support Level | $11.53 | $13.97 |
| Resistance Level | $12.53 | $14.99 |
| Average True Range (ATR) | 1.01 | 0.41 |
| MACD | -0.22 | -0.01 |
| Stochastic Oscillator | 14.44 | 47.73 |
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.